AU8440975A - E. coli vaccine - Google Patents

E. coli vaccine

Info

Publication number
AU8440975A
AU8440975A AU84409/75A AU8440975A AU8440975A AU 8440975 A AU8440975 A AU 8440975A AU 84409/75 A AU84409/75 A AU 84409/75A AU 8440975 A AU8440975 A AU 8440975A AU 8440975 A AU8440975 A AU 8440975A
Authority
AU
Australia
Prior art keywords
coli vaccine
vaccine
coli
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU84409/75A
Other languages
English (en)
Inventor
Michael R Wilson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Canadian Patents and Development Ltd
Original Assignee
Canadian Patents and Development Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canadian Patents and Development Ltd filed Critical Canadian Patents and Development Ltd
Publication of AU8440975A publication Critical patent/AU8440975A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/025Enterobacteriales, e.g. Enterobacter
    • A61K39/0258Escherichia
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU84409/75A 1974-09-02 1975-08-29 E. coli vaccine Expired AU8440975A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3827974A GB1472624A (en) 1974-09-02 1974-09-02 Enteric disease vaccine

Publications (1)

Publication Number Publication Date
AU8440975A true AU8440975A (en) 1977-03-03

Family

ID=10402419

Family Applications (1)

Application Number Title Priority Date Filing Date
AU84409/75A Expired AU8440975A (en) 1974-09-02 1975-08-29 E. coli vaccine

Country Status (9)

Country Link
JP (1) JPS5151514A (Direct)
AU (1) AU8440975A (Direct)
BE (1) BE832967A (Direct)
DE (1) DE2538994A1 (Direct)
DK (1) DK386875A (Direct)
FR (1) FR2282908A1 (Direct)
GB (1) GB1472624A (Direct)
NL (1) NL7510120A (Direct)
ZA (1) ZA755043B (Direct)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2466251B1 (fr) * 1979-10-03 1983-03-18 Agronomique Inst Nat Rech Vaccin animal anticolibacillaire, obtention et application
IL59663A (en) * 1980-03-19 1983-02-23 Univ Ramot Vaccines obtained from bacterial mutant strains of enterobacteriaceae and pseudomonaceae
AU559550B2 (en) * 1981-03-09 1987-03-12 Cetus Corporation Vaccines
US5137721A (en) * 1981-03-09 1992-08-11 Cetus Corporation Employing strains of E. coli expressing non-indigenous adhesins and toxoids of E. coli
CA1338705C (en) * 1981-10-22 1996-11-12 Roy Curtiss Iii Vaccines obtained from antigenic gene products of recombinant genes
US4971794A (en) * 1982-09-02 1990-11-20 Unilever Patent Holdings B.V. Production of antibodies using a mixture of strains of E. coli collectively expressing type I pili, CFA I pili, CFA II pili and K88 pili
NZ205392A (en) * 1982-09-02 1987-03-06 Unilever Plc Preparation of immunoglobulins against e.coli pili
WO1985003521A1 (en) * 1984-02-01 1985-08-15 Enterovax Research Pty. Ltd. Bacterial strains
DK219084D0 (da) * 1984-05-02 1984-05-02 Frederik Carl Peter Lindberg Antigen
SE9100556D0 (sv) * 1991-02-26 1991-02-26 Holmgren Jan Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e coli bacteria in humans
EP0659086B1 (en) * 1992-09-04 1998-11-11 The University of Saskatchewan Novel bacterial vaccines using vaccine strains of pathogenic bacteria

Also Published As

Publication number Publication date
DE2538994A1 (de) 1976-06-16
JPS5151514A (en) 1976-05-07
ZA755043B (en) 1976-06-30
FR2282908B1 (Direct) 1978-11-10
BE832967A (fr) 1975-12-31
FR2282908A1 (fr) 1976-03-26
DK386875A (da) 1976-03-03
GB1472624A (en) 1977-05-04
NL7510120A (nl) 1976-03-04

Similar Documents

Publication Publication Date Title
NL7512365A (nl) Bevestiging.
CS351975A2 (en) Zpusob pripravy methyl-terc.butyletheru zpusob pripravy methyl terc.butyletheru
ZA751193B (en) 1,1-diaryl-1-oxadiazol-alkylamines
IL46736A (en) Substituted n-phenyl-2-trifluoro-methyl-4,6-dinitroanilines
AU8440975A (en) E. coli vaccine
HK56980A (en) 6-methyl-8alpha-n,n-dimethylsulphamoylaminoergoline i
AU7587674A (en) Infouenza vaccines
IE42364L (en) Hydroxyphenylacetonitriles.
ATA392274A (de) Einrichtung zum antrieb einer durchbiegungsausgleichwalze
GB1401048A (en) Spiro-indan-1,3-pyrrolidines
IL48002A0 (en) 5-cyanoalkyl-1,3,4-thiadiazole-2-ylureas
AU5949773A (en) Tge virus vaccine
IL47487A0 (en) 9-thia-or oxothia-and dioxothia-11,12-seco-prostaglandins
AU7096274A (en) Vaccine
AU503647B2 (en) Antipregnancy vaccine
JPS5125783A (en) Zetsuendensen no zetsuentaihakurihoho
JPS5115105A (en) Judoki no kyusokukatsuteisonshitsunasuitsuchinguyokairo
CA998474A (en) Modified bar code
IL46670A0 (en) 1,2,4-triazolidin-3-ones
IE42189L (en) Azetidinylsulphinyl chlorides.
ZA718451B (en) 4-alkoxy-1,2-methylenedioxybenzenes
AU4173472A (en) Vaccine
JPS5125289A (en) Mankonbea no sukaatogaadoanzensochi
JPS5125290A (en) Mankonbea no rankan
JPS5126044A (en) Dodenseitonaa no tenshahoho